Skip to content
JGO Weekly Summary (August 20, 2024) episode artwork

Aug 19, 2024 9 min

JGO Weekly Summary (August 20, 2024)

from Journal of Gynecologic Oncology (JGO)

In this episode of the JGO Podcast, we explore two Editor's Choice studies focused on ovarian cancer. First, we delve into the work of Nozaki and colleagues, who investigate the role of specific biomarkers in predicting patient responses to PARP inhibitors. Their findings challenge the conventional reliance on genomic instability scores alone and offer new insights into personalized treatment strategies. Next, we discuss the study by Yuan and colleagues, which examines how a history of breast cancer affects the response to PARP inhibitors in ovarian cancer patients with BRCA1/2 mutations. Tune in to discover how these groundbreaking studies could shape the future of ovarian cancer treatment. Article #1: Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer (https://doi.org/10.3802/jgo.2024.35.e55) Article #2: PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer (https://doi.org/10.3802/jgo.2024.35.e51)

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

JGO Weekly Summary (August 20, 2024)

0:00 9:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Journal of Gynecologic Oncology (JGO)?

This episode is 9 minutes long.

When was this Journal of Gynecologic Oncology (JGO) episode published?

This episode was published on August 19, 2024.

Can I download this Journal of Gynecologic Oncology (JGO) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.